Sialix this week appointed Norrie Russell president and CEO – a newly established full-time position at the company.
Previously Russell was president of Gene Logic, the US operating division of Ocimum Biosolutions. Before that he was president and chief operating officer of NovaRx and chief scientific officer at Invitrogen, now Life Technologies.
Biognosys announced this week that it has added Ignacio Martinez, Hellmut Kirchner, and Harry Welton to its board of directors.
Martinez is a principal at Syngenta Ventures, a participant in the CHF2.7 million ($3 million) funding round the company announced this week (see story this issue). Kirchner is co-founder of the venture fund TVM, also a participant in the funding round. Welton has served as chief financial officer of several biotech firms including Arpida.
Vermillion this week entered into a consulting agreement with Eric Fung under which Fung will continue to serve as the company's chief medical officer and member of its scientific advisory board but will be paid on an hourly basis.